
CVRx Investor Relations Material
Latest events

Q4 2024
CVRx
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from CVRx Inc
Access all reports
CVRx develops and commercializes neuromodulation solutions for patients with heart failure. CVRx's first product, Barostim, is a investigational device that delivers low-energy electrical stimulation to the left ventricle through cardiac leads inserted into veins that leave the left ventricle.
Key slides for CVRx Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
CVRx Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
CVRx Inc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
CVRX
Country
🇺🇸 United States